Lennox Abigail 4

What Happened

• Abigail Lennox, EVP and Chief Scientific Officer of Perrigo Company plc (PRGO), received an award of 31,607 restricted stock units (RSUs) on 2026-05-13 (transaction code A). No purchase price or cash value is listed in the filing; these are derivative awards representing the right to receive ordinary shares upon vesting. This is a compensation grant (not an open-market purchase or sale).

Key Details

• Transaction date: 2026-05-13; Form 4 filed 2026-05-15 (timely within reporting window).
• Award: 31,607 RSUs; price listed as N/A (derivative award).
• Shares owned after transaction: Not stated in the provided filing.
• Footnotes: Each RSU represents a contingent right to one Perrigo ordinary share. Vesting occurs in three equal annual installments beginning May 13, 2027.
• Transaction code: A (award/grant).

Context

• RSUs are contingent awards that convert to actual shares only as they vest and may be subject to forfeiture until then; they do not require an immediate cash outlay by the insider. Such grants are generally part of executive compensation and should be viewed as routine company pay practices rather than an explicit buy/sell signal.